Published in BMJ Case Rep on January 23, 2009
Deep brain stimulation for the treatment of addiction: basic and clinical studies and potential mechanisms of action. Psychopharmacology (Berl) (2013) 0.99
Nucleus accumbens deep brain stimulation results in insula and prefrontal activation: a large animal FMRI study. PLoS One (2013) 0.95
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction (1993) 41.55
The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry (2005) 12.53
Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear. Cell (2002) 2.09
The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat (2003) 2.08
Alcohol-responsive genes in the frontal cortex and nucleus accumbens of human alcoholics. J Neurochem (2005) 1.73
Clinical study for alleviating opiate drug psychological dependence by a method of ablating the nucleus accumbens with stereotactic surgery. Stereotact Funct Neurosurg (2003) 1.59
Glutamate-mediated transmission, alcohol, and alcoholism. Neurochem Int (2000) 1.54
Drug therapy for alcohol dependence. N Engl J Med (1999) 1.54
Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors. Eur J Pharmacol (2003) 1.44
Differential adaptive properties of accumbens shell dopamine responses to ethanol as a drug and as a motivational stimulus. Eur J Neurosci (2003) 1.10
Stereotactic neurosurgical treatment of addiction: minimizing the chances of another 'great and desperate cure'. Addiction (2006) 0.96
A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med (2006) 8.12
Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology (2007) 3.81
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol (2008) 2.83
Deep brain stimulation for psychiatric disorders. Dtsch Arztebl Int (2010) 2.60
Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year. Clin Neurol Neurosurg (2009) 2.57
Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry (2010) 2.46
Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder. Health Aff (Millwood) (2011) 2.34
The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat (2003) 2.08
Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood (2010) 1.77
Good vibrations: cross-frequency coupling in the human nucleus accumbens during reward processing. J Cogn Neurosci (2009) 1.69
Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1. J Biol Chem (2007) 1.63
Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications? J Neurol Neurosurg Psychiatry (2007) 1.56
Essential tremor and tremor in Parkinson's disease are associated with distinct 'tremor clusters' in the ventral thalamus. Exp Neurol (2012) 1.55
Stimulate or degenerate: deep brain stimulation of the nucleus basalis Meynert in Alzheimer dementia. World Neurosurg (2012) 1.55
Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position. J Neurosurg (2002) 1.51
Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization. J Biol Chem (2007) 1.51
Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma. Ann Neurol (2003) 1.50
Predicting acute affective symptoms after deep brain stimulation surgery in Parkinson's disease. Stereotact Funct Neurosurg (2010) 1.46
Clinical outcome of subthalamic stimulation in Parkinson's disease is improved by intraoperative multiple trajectories microelectrode recording. J Neurol Surg A Cent Eur Neurosurg (2012) 1.42
The causal relationship between subcortical local field potential oscillations and Parkinsonian resting tremor. J Neural Eng (2010) 1.41
Ten-Hertz stimulation of subthalamic nucleus deteriorates motor symptoms in Parkinson's disease. Mov Disord (2004) 1.40
Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology (2012) 1.38
Deep brain stimulation of the nucleus accumbens and the internal capsule in therapeutically refractory Tourette-syndrome. J Neurol (2007) 1.33
Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Biol Psychiatry (2008) 1.31
Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab (2004) 1.28
Noxa/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells. J Biol Chem (2011) 1.24
S-peptide epitope tagging for protein purification, expression monitoring, and localization in mammalian cells. Biotechniques (2004) 1.21
Nuclei accumbens phase synchrony predicts decision-making reversals following negative feedback. J Neurosci (2009) 1.21
Intracranial EEG correlates of expectancy and memory formation in the human hippocampus and nucleus accumbens. Neuron (2010) 1.20
Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol (2004) 1.17
Frequency-dependent reciprocal modulation of verbal fluency and motor functions in subthalamic deep brain stimulation. Arch Neurol (2006) 1.16
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol (2013) 1.15
Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation. Arch Neurol (2009) 1.15
Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Mov Disord (2003) 1.14
Sensory gating revisited: relation between brain oscillations and auditory evoked potentials in schizophrenia. Schizophr Res (2007) 1.14
Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis. Strahlenther Onkol (2004) 1.14
Visualization of abscess formation in a murine thigh infection model of Staphylococcus aureus by 19F-magnetic resonance imaging (MRI). PLoS One (2011) 1.12
Context-dependent Bcl-2/Bak interactions regulate lymphoid cell apoptosis. J Biol Chem (2009) 1.12
Deep brain stimulation: what does it offer? Adv Neurol (2003) 1.09
Nucleus Accumbens is Involved in Human Action Monitoring: Evidence from Invasive Electrophysiological Recordings. Front Hum Neurosci (2008) 1.09
Deep brain stimulation as a new therapeutic approach in therapy-resistant mental disorders: ethical aspects of investigational treatment. Eur Arch Psychiatry Clin Neurosci (2009) 1.06
Neuroelectric signatures of reward learning and decision-making in the human nucleus accumbens. Neuropsychopharmacology (2008) 1.03
Deep brain stimulation for treatment-refractory obsessive compulsive disorder: a systematic review. BMC Psychiatry (2014) 1.03
Apoptosis in the treatment of cancer: a promise kept? Curr Opin Cell Biol (2006) 1.02
Coordinated reset neuromodulation for Parkinson's disease: proof-of-concept study. Mov Disord (2014) 1.00
Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson disease. Arch Gen Psychiatry (2003) 0.99
Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects of 12-month stimulation. World J Biol Psychiatry (2011) 0.99
Deep brain stimulation in the nucleus accumbens for intractable Tourette's syndrome: follow-up report of 36 months. Biol Psychiatry (2008) 0.99
Apoptosis-associated caspase activation assays. Methods (2008) 0.98
Influence of motility on the outcome of in vitro fertilization/intracytoplasmic sperm injection with fresh vs. frozen testicular sperm from men with obstructive azoospermia. Fertil Steril (2003) 0.98
Mood improvement after deep brain stimulation of the internal globus pallidus for tardive dyskinesia in a patient suffering from major depression. J Psychiatr Res (2006) 0.97
Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1beta and IL-6 production in autoimmune arthritis. J Rheumatol (2009) 0.97
Data-driven approach to the estimation of connectivity and time delays in the coupling of interacting neuronal subsystems. J Neurosci Methods (2010) 0.97
Lack of persistent changes in the dopaminergic system of rats withdrawn from methamphetamine self-administration. Eur J Pharmacol (2002) 0.96
Characterisation of tremor-associated local field potentials in the subthalamic nucleus in Parkinson's disease. Eur J Neurosci (2009) 0.95
Counteracting incentive sensitization in severe alcohol dependence using deep brain stimulation of the nucleus accumbens: clinical and basic science aspects. Front Hum Neurosci (2009) 0.94
Deep brain stimulation in the nucleus ventralis intermedius in patients with essential tremor: habituation of tremor suppression. J Neurol (2010) 0.93
Deep brain stimulation of the ventral intermediate nucleus in patients with essential tremor: stimulation below intercommissural line is more efficient but equally effective as stimulation above. Exp Neurol (2011) 0.93
Obsessive-compulsive disorder: development of demand-controlled deep brain stimulation with methods from stochastic phase resetting. Neuropsychopharmacology (2003) 0.93
Vascular dysfunction following polymicrobial sepsis: role of pattern recognition receptors. PLoS One (2012) 0.93
Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable? Mov Disord (2011) 0.92
In vivo evidence of deep brain stimulation-induced dopaminergic modulation in Tourette's syndrome. Biol Psychiatry (2011) 0.92
Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders. Schizophr Res (2009) 0.92
Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease. Mov Disord (2010) 0.92
Successful deep brain stimulation of the nucleus accumbens in severe alcohol dependence is associated with changed performance monitoring. Addict Biol (2011) 0.92
Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease. Mov Disord (2008) 0.91
Bithalamical deep brain stimulation in tourette syndrome is associated with reduction in dopaminergic transmission. Biol Psychiatry (2009) 0.90